Cassandra Mancini, MS, OTR/L | |
10588 Canterberry Rd, Fairfax Station, VA 22039-1930 | |
(703) 474-8342 | |
Not Available |
Full Name | Cassandra Mancini |
---|---|
Gender | Female |
Speciality | Occupational Therapist |
Location | 10588 Canterberry Rd, Fairfax Station, Virginia |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1679989842 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225X00000X | Occupational Therapist | 0119006260 (Virginia) | Primary |
225X00000X | Occupational Therapist | OT010000962 (District Of Columbia) | Secondary |
Mailing Address | Practice Location Address |
---|---|
Cassandra Mancini, MS, OTR/L 15 W Glebe Rd Apt C11, Alexandria, VA 22305-2684 Ph: (207) 807-6096 | Cassandra Mancini, MS, OTR/L 10588 Canterberry Rd, Fairfax Station, VA 22039-1930 Ph: (703) 474-8342 |
News Archive
A retrospective study of Ebola epidemics in the Democratic Republic of Congo (DRC) suggested that each day of delay in hospital admittance was associated with an 11% increased risk of death for Ebola patients during epidemics.
A new study published on the preprint server bioRxiv* in May 2020 reports the presence of ACE2 receptors in the eye at high concentrations. These molecules are the entry points for the SARS-CoV-2 virus that is causing the ongoing COVID-19 pandemic.
Cell Therapeutics, Inc. today announced that it has received a $5 million milestone payment from Teva Pharmaceutical Industries Ltd. related to the achievement of a sales milestone for TRISENOX (arsenic trioxide).
Since 2017, University of Alabama at Birmingham researchers Casey Morrow, Ph.D., and Hyunmin Koo, Ph.D., have used powerful genomic tools and supercomputers that analyze massive amounts of genetic data to identify individual strains within single species of the gut microbiome.
› Verified 8 days ago